Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors-Reference-Cited by-同舟云学术

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors

Author:

Long Aaron S.¹,Zhang Audrey D.²,Meyer Caitlin E.³,Egilman Alexander C.⁴,Ross Joseph S.⁴⁵⁶⁷,Wallach Joshua D.⁸

Affiliation:

1. Yale University School of Medicine, New Haven, Connecticut

2. Duke University Health System, Durham, North Carolina

3. Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, Connecticut

4. Center for Outcomes Research and Evaluation, New Haven, Connecticut

5. Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut

6. National Clinician Scholars Program, Yale School of Medicine, Department of Internal Medicine, New Haven, Connecticut

7. Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

8. Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

Reference28 articles.

2. Chiral switches.;Tucker;Lancet,2000

5. Chiral drugs: an overview.;Nguyen;Int J Biomed Sci,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Sulfoxides in medicine;Current Opinion in Chemical Biology;2023-10